NCT01884896View on ClinicalTrials.gov

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Fasting
Interventions
DRUG

Metoprolol Succinate ER Tablet 200 mg

1 \* 200 mg tablet per day

DRUG

'TOPROL-XL®' ER Tablets 200 mg

1 \* 200 mg tablet per day

Trial Locations (1)

380054

Cliantha Research Limited, Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY